Health Canada has given Moderna the green light to launch a clinical trial for a vaccine targeting the Bundibugyo form of the Ebola virus, which continues to surge throughout the Democratic Republic of the Congo.

Phase 1 trial will evaluate safety and immune response for a strain of Ebola virus disease with no licensed vaccines indicatedPhase 1 trial is being conducted in Canada as part of…

Results may be months away, but efforts are advancing towards enhanced treatment and the world’s first vaccine for the Bundibugyo species of Ebola, the World Health Organization…